Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Exercise-Induced Bronchospasm
NCT00090142Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2004
- Primary completion
- Oct 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of montelukast in Exercise-Induced Asthma (EIA), sponsored by Organon & Co.. Started May 2004; status: completed.
02
Drugs
montelukast
03
Conditions
Exercise-Induced Asthma (EIA)
Beyond the preview
Go deeper on NCT00090142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090142.